Gastroparesis
📧 Sign up to get email alerts when something new happens for Gastroparesis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-03-31FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals’ supplemental application for metoclopramide, updating the regulatory status of this generic drug.
-
FDA approval · 2010-03-31FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for metoclopramide (generic).
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis) [NA]
Clinical trial update for Enterra Therapy gastric electrical stimulation in gastroparesis; the study (NCT00157755) was terminated with resul…
-
FDA approval · 2009-12-01FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved Ipca Laboratories Limited's supplemental application for Metoclopramide, granting approval of a generic version of the drug. Th…
-
FDA approval · 2009-11-06FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's metoclopramide product, updating its regulatory status as a marketed generic drug.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-09-16FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for METOCLOPRAMIDE, authorizing the manufacture and marketing of a generic me…
-
FDA approval · 2009-09-11FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for METOCLOPRAMIDE HYDROCHLORIDE submitted by Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2009-09-04FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for REGLAN (metoclopramide hydrochloride), enabling changes under a supplemen…
-
FDA approval · 2009-06-30FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for metoclopramide hydrochloride (generic), filed by Chartwell Governmental & Specialty RX, LLC., as…
-
FDA approval · 2009-06-30FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Reglan (metoclopramide hydrochloride) submitted by ANI Pharmaceuticals, Inc. for NDA 017854.
-
FDA approval · 2009-06-30FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for metoclopramide.
-
FDA approval · 2008-10-28FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for metoclopramide from ANI Pharmaceuticals, Inc., for an already approved generic product. This…
-
FDA approval · 2008-06-12FDA Approved: METOCLOPRAMIDE — Original Application (Ipca Laboratories Limited)
FDA approved the original generic application for metoclopramide by Ipca Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2008-05-23Clinical Trial Update: A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old
A completed clinical trial comparing the SmartPill capsule with scintigraphy to determine gastric residence time in adults over 65 years old…
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time
A completed clinical trial comparing the SmartPill capsule with scintigraphy to determine gastric residence time in patients with gastrointe…
-
CLINICAL_TRIALS trial_result · 2008-03-20Clinical Trial Update: Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis [Phase 1]
Phase 1 trial assessing the safety and efficacy of intravenous TZP-101 in patients with diabetic gastroparesis. The study has completed.
-
FDA approval · 2007-12-21FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for Metoclopramide Hydrochloride (generic) from Chartwell Governmental & Specialty RX, LLC. The acti…
-
CLINICAL_TRIALS trial_result · 2007-11-20Clinical Trial Update: Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying [Phase 2]
A Phase 2 clinical trial evaluating tadalafil for symptoms of gastroparesis in diabetic patients has completed. The sponsor is Eli Lilly and…
-
FDA label_change · 2007-01-24FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for metoclopramide from Teva Pharmaceuticals USA, Inc., resulting in changes to the product labe…
-
CLINICAL_TRIALS other · 2007-01-22Clinical Trial Update: Effect of Electroacupuncture in Diabetic Patients With Gastroparesis [Phase 3]
Phase 3 clinical trial update investigating electroacupuncture for gastroparesis in patients with diabetes; current status is not provided.